Evorel Conti 3,1 mg/3,2 mg Transdermal patch
PDF Leaflet Revision Date: 17 December 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Hormone replacement therapy for menopausal symptoms.
Dosage (summary)
Apply twice weekly, not exceeding 5 years.
Special Populations
- Elderly
- Liver impairment
- Kidney impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Barbiturates
- Carbamazepine
- Rifampicin
- St. John's wort
Contraindications
- Hypersensitivity
- Breast cancer
- Endometrial cancer
- Active liver disease
- Thromboembolic disorders
Common side effects
- Depression
- Headache
- Nausea
- Hypertension
- Application site reaction
Counselling Points
- Apply to clean, dry skin
- Avoid contact with adhesive
- Monitor for mood changes
- Do not use as contraception
Serious warnings
- Increased risk of breast cancer
- Risk of thromboembolism
- Mood changes and depression
Important Disclaimer
The Evorel Conti 3,1 mg/3,2 mg Transdermal patch professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
